A case of hypertrophic spinal pachymeningitis associated with MPO-ANCA

Clinical Neurology

Volumn 42, Issue 9, 2002, Pages 873-877

  Yakushiji, Yusuke ^a   Kurohara, Kazuhiro ^a   Toda, Shuji ^a   Abe, Masamitsu ^a   Kuroda, Yasuo ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

Cerebrospinal fluid; Corticosteroid; Hypertrophic pachymeningitis; Magnetic resonance imaging; Myeloperoxidase anti neutrophil cytoplasmic antibody (MPO ANCA)

Indexed keywords

GADOLINIUM; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISOLONE;

AGED; ANTIBODY PRODUCTION; ARTICLE; BIOPSY TECHNIQUE; CASE REPORT; CERVICAL MYELOPATHY; CONTRAST ENHANCEMENT; CORTICOSTEROID THERAPY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DURA MATER; EARLY DIAGNOSIS; HOSPITAL ADMISSION; HUMAN; HYPERTROPHIC SPINAL PACHYMENINGITIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN LOCALIZATION; SPINAL CORD DISEASE; THICKNESS; THORACIC TRANSVERSE MYELOPATHY; THORAX INJURY;

ADMINISTRATION, ORAL; AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; BIOLOGICAL MARKERS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MENINGITIS; PEROXIDASE; PREDNISOLONE; TREATMENT OUTCOME;

EID: 0036770262     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Takahashi K. Kobayashi S. Okada K. et al: Pachymeningitis with a perinuclear antineutrophil cytoplasmic antibody: response to pulse steroid. Neurology 50: 1190-1191, 1998
2. Case records of the Massachusetts General Hospital. Case 9-1999. N Engl J Med 340: 945-953, 1999
3. Tamai H. Tamai K. Yuasa H: Pachymeningitis with Pseudo-Foster Kennedy Syndrome. Am J Ophthalmol 130: 535-537, 2000
4. Nagashima T. Maguchi S. Terayama Y. et al: P-ANCA-positive Wegener's granulomatosis presenting with hypertrophic pachymeningitis and multiple cranial neuropathies: case report and review of literature. Neuropathology 1: 23-30, 2000
5. Kono H. Inokuma S. Nakayama H. et al: Pachymeningitis in microscopic polyangiitis (MPA): a case report and a review of central nervous system involvement in MPA. Clin Exp Rheumatol 18: 397-400, 2000
6. Funauchi M. Yoo BS. Sugiyama M, et al: A case of rheumatoid meningitis positive for perinuclear antineutrophil cytoplasmic antibody. Ann Rheum Dis 59: 1001-1002, 2000
7. Takuma H. Shimada H. Inoue Y. et al: Hypertrophic pachymeningitis with anti-neutrophil cytoplasmic antibody (p-ANCA). and diabetes insipidus. Acta Neurol Scand 104: 397-401, 2001
8. Prange HW. Moskophidis M. Schipper HI. et al: Relationship between neurological features and intrathecal synthesis of IgG antibodies to Treponema pallidum in untreated and human neurosyphilis. J Neurol 230: 241-252, 1983
9. Gribble LD: Syphilitic spinal pachymeningitis, S Afr Med J 46: 1326-1328, 1972
10. Guidetti B, La Torre E: Hypertrophic spinal pachymeningitis. J Neurosurg 26: 496-503, 1967
11. Selby R: Pachymeningitis secondary to Allescheria boydii. J Neurosurg 36: 225-227, 1972
12. Gutmann L, Hable K: Rheumatoid pachymeningitis. Neurology 13: 901-905, 1963
13. Kuramochi S. Hosoda Y. Matsuyama H. et al: Thromboendophlebitis obliterans of the dural sinuses associated with hypertrophic pachymeningitis. Vasc Surg 13: 104-110, 1979
14. Bucy PC. Freeman LW: Hypertrophic spinal pachymeningitis with special reference to appropriate surgical treatment. J Neurosurg 9: 564-578, 1952
15. Huang H. Haq N: Spinal leptomeningeal sarcoidosis. Neuroradiology 29: 100, 1987
16. Paulson GW, Meagher JN, Burkhart J: Spinal pachymeningitis secondary to mucopolysaccharidosis. J Neurosurg 41: 618-621, 1974
17. Bernat JL. Sadowsky CH. Vincent FM, et al: Sclerosing spinal pachymeningitis. A complication of intrathecal administration of Depo-Medrol for multiple sclerosis. J Neurol Neurosurg Psychiatry 39: 1124-1128, 1976
18. Davies DJ. Moran JE. Niall JF. et al: Segmental necrotising glomerulonephritis with antineutrophil cytoplasmic antibody. Possible arbovirus aetiology? Br Med J 285: 606, 1982
19. Falk RJ. Jennette JC: Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 318: 1651-1657, 1988
20. Gross WL, Schmitt WH, Csernok E: ANCA and associated diseases: immunologic and pathogenetic aspects. Clin Exp Immunol 91: 1-12. 1993
21. Fauci AS, Haynes BF. Katz P: The spectrum of vasculitis: clinical, pathological, immunologic and therapeutic considerations. Ann Intern Med 89: 660-676, 1978